This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignee: Nucelis Inc.. Active years: 2013-2024.
Company Filing History:
Years Active: 2013-2024
Title: Innovations of Noel M Fong in Isoprenoid Production
Introduction
Noel M Fong is a notable inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in the production of isoprenoids. With a total of four patents to his name, Fong's work focuses on enhancing yeast strains for improved production of valuable compounds.
Latest Patents
Fong's latest patents include innovative methods for producing isoprenoids, specifically squalene, through genetically modified yeast. One of his patents details yeast strains expressing an HMG-CoA reductase with increased activity or expression. This invention provides compositions and methods for producing isoprenoids, including squalene, using genetically converted yeast. Another patent outlines methods of producing squalene using both genetically altered and non-genetically altered yeast. These advancements highlight Fong's commitment to improving the efficiency of squalene production through biotechnological means.
Career Highlights
Throughout his career, Noel M Fong has worked with various companies, including Nucelis Inc. and Cibus Europe, B.V. His experience in these organizations has allowed him to develop and refine his innovative approaches to biotechnology. Fong's work has not only contributed to scientific knowledge but has also had practical applications in the industry.
Collaborations
Fong has collaborated with notable professionals in his field, including Keith A Walker and Mark E Knuth. These partnerships have likely enhanced his research and development efforts, leading to the successful patenting of his inventions.
Conclusion
Noel M Fong's contributions to the field of biotechnology, particularly in the production of isoprenoids, demonstrate his innovative spirit and dedication to advancing scientific knowledge. His patents reflect a significant step forward in the efficient production of valuable compounds, showcasing the potential of genetically modified organisms in industrial applications.